VeriMomdecursinol hamilelikte güvenli mi?
No harmonised CLP classification, SCCS/CIR opinions or regulatory reproductive hazard listings were identified for decursinol; however peer‑reviewed studies show biological activity relevant to implantation/angiogenesis (in vitro increases in endometrial adhesion molecule expression and in vivo/in vitro inhibition of VEGF‑driven angiogenesis), which constitutes demonstrated mechanistic effects that could plausibly influence pregnancy. There are no animal or human reproductive‑toxicity data showing teratogenicity or pregnancy harm for decursinol. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32024510/))
Related ingredients
Frequently asked questions
- decursinol hamilelikte güvenli mi?
- No harmonised CLP classification, SCCS/CIR opinions or regulatory reproductive hazard listings were identified for decursinol; however peer‑reviewed studies show biological activity relevant to implantation/angiogenesis (in vitro increases in endometrial adhesion molecule expression and in vivo/in vitro inhibition of VEGF‑driven angiogenesis), which constitutes demonstrated mechanistic effects that could plausibly influence pregnancy. There are no animal or human reproductive‑toxicity data showing teratogenicity or pregnancy harm for decursinol. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32024510/))
- decursinol emzirirken güvenli mi?
- No data were found showing transfer into milk, human lactation exposure, or reproductive classification for decursinol. No regulatory (CIR/SCCS/harmonised CLP) guidance or clinical reports were identified to indicate a breastfeeding hazard. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32024510/))
- decursinol bebek cildi için güvenli mi?
- No infant‑specific safety or dermal‑absorption studies were located. Adult topical cosmetic exposure literature/regulatory sources are absent; because decursinol is a small lipophilic coumarin derivative with measurable bioactivity and dermal use in research contexts, neonatal/infant skin exposure is conservatively assigned higher exposure (+1) due to immature barrier and higher surface‑area:weight; no evidence was found to increase hazard or mechanism scores for infants. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/19228635/?utm_source=openai))
- VeriMom decursinol nasıl puanlıyor?
- VeriMom decursinol'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 87/100 (düşük risk) olarak puanlar.
- Hamilelikte decursinol yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.